rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PODD
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Tandem upgraded, Insulet downgraded at Stifel on market for tubeless insulin pumps

      Tandem Diabetes Care (TNDM) stock gains and Insulet (PODD) slips as Stifel changes their ratings, citing the market trends for tubeless insulin pumps. Read more here.

      8h agoSeeking AlphaPODDTNDMSF
      Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
      12h agoYahoo FinancePODDTNDM
      This Insulet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
      14h agoBenzingaPODD
      Stifel downgrades Insulet stock rating on U.S. momentum concerns
      18h agoInvesting.comPODD
      Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy Counter

      Insulet is undervalued, trading at a sub-median multiple despite 20% revenue growth and expanding margins. Learn more about PODD stock here.

      Nov 11Seeking AlphaPODD
      Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
      Nov 10Yahoo FinancePODD
      Insulet Corp. stock rises Monday, still underperforms market
      Nov 9MarketWatchPODD
      Truist raises Insulet stock price target on Q4 guidance beat
      Nov 9Investing.comPODD
      Insulet Sees Attractive Valuation Despite More Conservative 2027 Outlook, RBC Says
      Nov 5Yahoo FinancePODD
      Insulet Stock What’s Changed After Earnings Beat
      Nov 5Yahoo FinancePODD
      Insulet Corp (PODD) Q3 2026 Earnings Call Highlights: Revenue Up 19%, EPS Jumps 60% and $1 ...

      Insulet Corp (PODD) delivered nearly 20% revenue growth with 490 basis points of operating margin expansion, while guiding 2027 growth modestly below mid-teens amid new competition.

      Nov 5Yahoo FinancePODD
      Jefferies raises Insulet stock price target to $200 on strong results
      Nov 4Investing.comPODD
      TD Cowen raises Insulet stock price target to $163 on Omnipod strength
      Nov 4Investing.comPODD
      Insulet CEO Sees Slower Growth in 2027, Expects Rivals to Chip Away at Omnipod's Market Share
      Nov 4BenzingaPODD
      What Insulet (PODD) Said on Its Q3 Earnings Call
      Nov 4Yahoo FinancePODD
      Insulet Corporation Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinancePODD
      Insulet Q3 2026 slides: strong beat, but 2027 outlook tempers gains
      Nov 4Investing.comPODD
      Insulet Q3 2026 Earnings Call Transcript
      Nov 4BenzingaPODD
      Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

      While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

      Nov 4Yahoo FinancePODD
      Insulet Q3 Adjusted Earnings, Revenue Rise; 2026 EPS Outlook Maintained
      Nov 4Yahoo FinancePODD
      Insulet (NASDAQ:PODD) posts better-than-expected sales in Q3 2026, stock soars
      Nov 4Yahoo FinancePODD
      Insulet (PODD) Q3 Earnings and Revenues Surpass Estimates
      Nov 4Yahoo FinancePODD
      Insulet: Q3 Earnings Snapshot

      (PODD) on Wednesday reported third-quarter net income of $141.The Acton, Massachusetts-based company said it had net income of $2.

      Nov 4Yahoo FinancePODD
      Insulet earnings up next: Can type 2 diabetes offset share pressure?
      Nov 3Investing.comPODD
      Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains
      Oct 29MarketWatchPODD
      Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth
      Oct 28Yahoo FinancePODD
      Insulet's Quarterly Earnings Preview: What You Need to Know
      Oct 27BarchartPODD
      Insulet (PODD) Could Be 11% Undervalued On Omnipod Discover Launch
      Oct 26Yahoo FinancePODD
      Insulet Corp. stock outperforms competitors on strong trading day
      Oct 16MarketWatchPODD
      Insulet Corp. stock underperforms Wednesday when compared to competitors
      Oct 14MarketWatchPODD
      Insulet Corp. stock outperforms competitors despite losses on the day
      Oct 13MarketWatchPODD
      Insulet Corp. stock outperforms competitors on strong trading day
      Oct 12MarketWatchPODD
      Insulet Launches Omnipod Discover Platform Across US
      Oct 12Yahoo FinancePODD
      Insulet launches Omnipod Discover data platform in U.S.
      Oct 12Investing.comPODD
      Jefferies cuts Insulet stock price target on competition concerns
      Oct 12Investing.comPODD
      Insulet Announces Omnipod Discover Now Available in U.S.
      Oct 12Yahoo FinancePODD
      Leerink Partners Adjusts Insulet Price Target to $143 From $145
      Oct 9Yahoo FinancePODD
      Insulet Reports Q2 2026 Results: Full Earnings Call Transcript - Insulet (NASDAQ:PODD)

      Insulet (NASDAQ:PODD) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data

      Oct 8BenzingaPODD
      Insulet Corp. stock outperforms competitors on strong trading day
      Oct 5MarketWatchPODD
      Analysts Offer Insights on NA Companies: Insulet (PODD) and General Motors (GM)

      Detailed price information for General Motors Company (GM-N) from The Globe and Mail including charting and trades.

      Oct 1The Globe and MailPODDGM
      Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

      ACTON, Mass., October 01, 2026--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the third quarter of 2026 on Wednesday, November 4, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time).

      Oct 1Yahoo FinancePODD
      Insulet Corp. stock outperforms competitors despite losses on the day
      Sep 30MarketWatchPODD
      Insulet Corp. stock underperforms Monday when compared to competitors
      Sep 28MarketWatchPODD
      Why is Insulet stock sliding today?
      Sep 28Investing.comPODD
      Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says

      Insulet (PODD) sees emerging headwinds from new market entrants in 2027 and 2028, with the debate ar

      Sep 28Yahoo FinancePODD
      Insulet (PODD) Stock May Trade At A Discount To Fair Value

      Insulet has seen its share price fall hard over the past year, which puts the focus squarely on whether the current market value still lines up with the cash the business is expected to generate. With the stock under pressure, the key issue now is how its cash flows compare with the price investors are paying today. Over the past 12 months, Insulet shares have declined 57.2%. This puts a lot of weight on whether the business can support the present valuation through its future cash...

      Sep 26Yahoo FinancePODD
      Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap?

      Insulet (PODD) recently reworked its financing by replacing $475 million of term loans with new debt at lower interest margins and expanding its revolving credit facility, a move that directly reshapes the balance sheet. Insulet’s refinancing lands after a tough stretch for the stock, with the share price down 52% year to date and the 1 year total shareholder return declining 58%. This points to fading momentum even before its recent index removal and conference appearances. Scan beyond...

      Sep 25Yahoo FinancePODD
      Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum
      Sep 25Yahoo FinancePODD
      Insulet at Bernstein healthcare forum: growth, retention and new AID push
      Sep 24Investing.comPODD
      How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
      Sep 24BarchartPODD

      This is the newest page. Registered accounts read further back.